Site and Rate Selective Prodrug Formulations of D609 with Antioxidant and Anticancer Activity
    3.
    发明申请
    Site and Rate Selective Prodrug Formulations of D609 with Antioxidant and Anticancer Activity 审中-公开
    D609抗氧化和抗癌活性的筛选和筛选方法

    公开(公告)号:US20070244076A1

    公开(公告)日:2007-10-18

    申请号:US10575188

    申请日:2004-10-08

    IPC分类号: A61K31/66 A61K31/265 C07F9/06

    CPC分类号: C07F9/091

    摘要: Compounds that are heteroatom substituted alkyl derivatives of tricyclodecan-9-yl-xanthogenate, and pharmaceutical compositions of these compounds, are disclosed. Methods of treating a disease or disorder in a subject and methods of protecting normal tissues in a subject from toxicity associated ionizing radiation or chemotherapy using compositions comprising these novel compounds are also disclosed. The invention also concerns methods of treating a disease or disorder in a subject using compositions that include these novel compounds while concurrently or consecutively treating the subject with ionizing radiation or a chemotherapeutic agent.

    摘要翻译: 公开了作为三环癸基-9-基 - 黄原酸酯的杂原子取代的烷基衍生物的化合物和这些化合物的药物组合物。 还公开了治疗受试者的疾病或病症的方法以及使用包含这些新化合物的组合物来保护受试者中与正常组织相关的电离辐射或化学疗法的组合物的方法。 本发明还涉及使用包括这些新化合物的组合物治疗受试者的疾病或病症的方法,同时或连续地用电离辐射或化学治疗剂治疗受试者。